Jaiswal MK
in patients with T2DM (38) found that continuous GLP-1 administration via a subcutaneous pump to raise serum GLP-1 levels from a mean of 9.7 pM at baseline to 282 pM over 6 weeks significantly reduced plasma glucose concentrations, improved glycated hemoglobin, and enhanced insulin sensitivity and -cell function compared to placebo, with no significant limiting side effects reported
Your Health Magazine Contributor More Weight Control, Nutrition & Exercise Articles What is the Difference Between GLP-1, GLP-2, and GLP-3
others report billing problems, unhelpful customer service, and a few accusations of fraudulent practices
Price Comparison This dupe is $0.01 more expensive than the original product
Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C, DAlessio DA, Davies MJ